Pharmaceutical Distribution

Reliable Supply.
Healthier Communities.

A MCAZ-compliant pharmaceutical distribution platform — connecting manufacturers to patients across Zimbabwe and the SADC region.

The Platform

Distribution Infrastructure
Built for Southern Africa.

AfriPharma is developing a fully compliant pharmaceutical distribution platform in Zimbabwe — with a Harare Distribution Centre being established in Msasa, and a MCAZ Wholesale Distribution Permit (WDP) application in progress.

Our distribution operations are designed to meet the highest regulatory standards from day one — building the compliance track record needed for DFI engagement, institutional supplier partnerships, and regional expansion.

MCAZ — Zimbabwe
BoMRA — Botswana
SAHPRA — South Africa
ZAMRA — Zambia
ZAZIBONA
GDP Aligned
Harare Distribution Centre

Msasa, Harare — Zimbabwe

  • MCAZ-compliant zone layout
  • Quarantine and rejected goods segregation
  • Temperature monitoring (T1–T4 points)
  • Cold-chain integrity systems
  • CCTV surveillance and pest control
  • Responsible Pharmacist workstation
Customers

Who We Serve.

AfriPharma's distribution platform is built to serve every node of the healthcare supply chain.

Hospitals

Clinics

Pharmacies

NGOs

Healthcare Providers

Distribution Focus

Our Distribution
Commitments.

  • Quality-assured medicines — sourced exclusively from registered, reputable manufacturers with full documentation
  • Regulatory compliance — MCAZ WDP application in progress; GDP-aligned SOPs operational from day one
  • Cold-chain integrity — temperature-controlled storage and transport for products requiring refrigeration
  • Supply-chain resilience — diversified supplier base to ensure consistent product availability
  • Technology-enabled operations — digital inventory management, order tracking, and documentation systems
  • QMS and SOP framework — comprehensive Quality Management System aligned to MCAZ SOP LE 67 requirements

Opening SKU Strategy

AfriPharma's distribution footprint is being built market by market — with Zimbabwe as the operational anchor and Botswana, South Africa, and Zambia in the pipeline.

AfriPharma's opening product focus is intentionally narrow and high-volume with products that have strong market demand and proven supply chains.

Regional Expansion

From Zimbabwe
to the SADC Region.

AfriPharma's distribution footprint is being built market by market — with Zimbabwe as the operational anchor and Botswana, South Africa, and Zambia in the pipeline.

Zimbabwe — Phase 1

Primary market. MCAZ WDP application active. Harare DC in Msasa under development.

Botswana — Phase 1

Entity incorporated April 2026.

South Africa — Phase 2

SAHPRA-aligned compliance preparation underway. Entity formation planned.

Zambia — Phase 3

ZDA engagement active. ZAMRA and ZAMSA introduction documents prepared. Ministry of Health and Ministry of Commerce and Trade outreach in progress.